The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Is BPC157 Legal? WADA, FDA Status, and What You Need to Know FDA mulls compounding for peptides previously flagged over safety risks BioSpace Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law FDA Enforcement In 2025: What The Data Reveals So Far